Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fibrillation after catheter ablation: A long term follow-up

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 5, 2012, Pages 532-543

  Berkowitsch, Alexander ^a   Kuniss, Malte ^a   Greiss, Harald ^a   Wójcik, MacIej ^a   Zaltsberg, Sergey ^a   Lehinant, Stefan ^a   Erkapic, Damir ^a   Pajitnev, Dimitri ^a   Pitschner, Heinz Friedrich ^a   Hamm, Christian W ^a   Neumann, Thomas ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

atrial fibrillation; catheter ablation; cryoballoon ablation; metabolic syndrome; renal function

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BALLOON CATHETER; BODY MASS; CATHETER ABLATION; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; COMORBIDITY; FEMALE; GERMANY; HUMANS; KIDNEY DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84860840825     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03350.x     Document Type: Article

References (26)

1. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA,. Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994; 271; 840-844.
2. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ,. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004; 292; 2471-2477.
3. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y,. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study. Am Heart J 2009; 158: 629-636.
4. Fabbian F, Catalano C, Lambertini D, Tarroni G, Bordin V, Squerzanti R, Gilli P, et al,. Clinical characteristics associated to atrial fibrillation in chronic hemodialysis pts. Clin Nephrol 2000; 54: 234-239.
5. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, Ma C,. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2009; 73: 438-443.
6. Chang SL, Tuan TC, Tai CT, Lin YJ, Lo LW, Hu YF, Tsao HM, et al,. Comparison of outcome in catheter ablation of atrial fibrillation in pts with versus without the metabolic syndrome. Am J Cardiol 2009; 1 (103): 67-72.
7. Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H, Igarashi M, et al,. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: A mid-term follow-up. Heart Rhythm 2011; 8: 335-341.
8. Tokuda M, Yamane T, Matsuo S, Ito K, Narui R, Hioki M, Tanigawa S, et al,. Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart 2011; 97: 137-142.
9. Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Suenari K, et al,. Associations between renal function, atrial substrate properties and outcome of catheter ablation in the pts with paroxysmal atrial fibrillation. Circ J 2011; 75:2326-2332.
10. Agostino RB, Jr,. Propensity scores in cardiovascular research. Circulation 2007; 115: 2340-2343.
11. Heinze G, and, Jüni P,. An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J 2011; 32: 1704-1708.
12. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, et al,. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735-2752.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D., A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): 1-266.
15. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, Kurzidim K, et al,. Circumferential pulmonary vein isolation with the cryoballoon technique results from a prospective 3-center study. J Am Coll Cardiol 2008; 52: 273-278.
16. Haïssaguerre M, Hocini M, Sanders P, Sacher F, Rotter M, Takahashi Y, Rostock T, et al,. Catheter ablation of long-lasting persistent atrial fibrillation: Clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 2005; 16: 1138-1147.
17. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ, Tsang TS,. Left atrial size physiologic determinants and clinical applications. J Am Coll Cardiol 2006; 47: 2357-2363.
18. Lam TK, Leung DT,. More on simplified calculation of body-surface area. N Engl J Med 1988; 318: 1130.
19. Berkowitsch A, Neumann T, Kuniss M, Janin S, Wojcik M, Zaltsberg S, Mitrovic V, et al,. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in pts with atrial fibrillation: Who is a responder? Pacing Clin Electrophysiol 2011; 33: 1101-1111.
20. Böhning D, Böhning W, Holling H,. Revisiting Youden's index as a useful measure of the misclassification error in meta-analysis of diagnostic studies. Statistical Methods Stat Methods Med Res 2008; 17: 543-554.
21. Letsas KP, Weber R, Bürkle G, Mihas CC, Minners J, Kalusche D, Arentz T,. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace 2009; 11: 158-163.
22. Berruezo A, Tamborero D, Mont L, Benito B, Tolosana JM, Sitges M, Vidal B, et al,. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007; 28: 836-841.
23. Duvnjak L, Bulum T, Metelko Å-,. Hypertension and the metabolic syndrome. Diabetologia Croatica 2008; 37: 83-89.
24. Khan SH, Khan FA, Ijaz A, Sattar A, Dilwar M, Hashim R,. Hypertension and metabolic syndrome: Impact of clustering of hypertension in subjects with metabolic syndrome. Pak Med Sci 2007; 23: 903-908.
25. Franklin SS,. Hypertension in the metabolic syndrome. Vol. IV: Metabolic syndrome and related disorders. Irvine, Mary Ann Liebert, Inc. 2005, pp. 287-298.
26. Schmidt M, Daccarett M, Ritger H, Marschang H, Holzmann S, Jung P, Bojanic D, et al,. Renal dysfunction and atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol 2011; 22:1092-1098.